SWINE FEVER VACCINE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

There are two types of swine fever – Classical Swine Fever (CSF) and African Swine Fever (ASF). Classical swine fever (CSF) is an extremely contagious viral disease in pigs. The severity of the disease varies with the strain of the virus, the immune status of the herd, and the age of the pig. African swine fever, on the other hand, is a highly contagious and deadly viral disease affecting both domestic and feral swine of all ages. Acute forms of both ASF and CSF can cause high death rates, with mortality approaching 100% in the most severe form of ASF. Both diseases may also occur in milder forms with lower mortality rates. Swine fever could be considered a possibility in case of a sudden increase in deaths in a group of pigs. Clinical signs of acute forms of both ASF and CSF include depression, fever, loss of appetite, and red, purple, or blue blotching of the ears, nose, and limbs. Vomiting and diarrhea (bloody diarrhea for ASF) may occur as the disease progresses, along with breathing difficulties and coughing. The diseases spread through direct contact with infected pigs or contact with contaminated pens, trucks, or clothing. In both diseases, pigs can remain carriers of the disease for long period and therefore moving pigs during an outbreak must be restricted.

Market Dynamics

Increasing efforts by the government bodies to create awareness and prevent the spread of swine fever by organizing awareness campaigns are expected to drive the market growth over the forecast period. For instance, in June 2022, the United States Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) announced new efforts to help prevent the introduction and spread of African swine fever in the U.S. Through an outreach and awareness campaign called “Protect Our Pigs,” APHIS will support commercial pork producers, veterinarians, and pig owners with information and resources to help safeguard America’s swine population and the pork industry.

Key features of the study:

• This report provides an in-depth analysis of the global swine fever vaccine market, market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global swine fever vaccine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Merck & Co., Inc. (Merck Animal Health), Ceva, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Indian Immunologicals Ltd., Bioveta, a.s., Komipharm, and EC21 Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global swine fever vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global swine fever vaccine market

Detailed Segmentation:

• Global Swine Fever Vaccine Market, By Type:
  • African Swine Fever
  • Classical Swine Fever
• Global Swine Fever Vaccine Market, By Vaccine Type:
  • Live-Attenuated
  • Chimeric (Live-attenuated or inactivated)
  • Subunit or vector system based
  • Replicon vaccine
• Global Swine Fever Vaccine Market, By Distribution Channel:
  • Public
  • Private
• Global Swine Fever Vaccine Market, By Region:
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Region
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Merck & Co., Inc. (Merck Animal Health)
  • Ceva
  • Zoetis Services LLC
  • Boehringer Ingelheim International GmbH
  • Indian Immunologicals Ltd.
  • Bioveta, a.s.
  • Komipharm
  • EC21 Inc.